Fiscal Year End Company Status Exempt Flag October 31 Trading N Board of Directors Name Position Devinder (Dev) Randhawa  Director of the Board Eldon R Smith  Director of the Board George Adams  Chairperson of the Board   Director of the Board Jeffrey A. Bacha  Director of the Board Justin Leushner  Director of the Board Philip Toleikis  Director of the Board   President William A. Cochrane  Director of the Board Incorporation Locations Inc. Date Expiry Date Country Region Description 19/Aug/1998    Canada  British Columbia    Exchange Filing Office Location Vancouver Regional Service Office		Business Type(s) Primary/Secondary Business Type Details Primary  Research And Development In The Life Sciences  The company is engaged in the research and development of a treatment for type 1 human diabetes using a transplanted device containing porcine cells.  Securities Symbol Security Name Market Status SVA Sernova Corp. TSX Venture TRADING Name History From To Sernova Corp. 20/Sep/2006 Present Company Facts Reconciliation Subject Date Returned Summer 2013 CFR Not Received Associations Auditing Firm:  Davidson & Company LLP Subsidiary:  Sertocell Biotechnology (US) Corp. Transfer Agent:  CIBC Mellon Trust Company
Latest Information Type Date Title News Releases  9/May/2013  NEWS RELEASE - SERNOVA PROVIDES CORPORATE UPDATE AND RESULTS OF 2013 ANNUAL GENERAL MEETING[MARKETWIRE]     NEWS RELEASE - ISSUES ADDITIONAL FINDER WARRANTS CANCELS OPTIO[MARKET NEWS]     NEWS RELEASE - SERNOVA ISSUES ADDITIONAL FINDER WARRANTS CANCELS OPTIONS[MARKETWIRE] Bulletins  22/Mar/2013  Amendment Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data